INCYIncyte CorporationNot started yet
A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy
CRC (Colorectal Cancer)
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 40 (planned)
- Started
- Oct 26, 2026
- Main results expected
- May 14, 2029
- Fully finished
- May 14, 2029
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Circulating tumor DNA (ctDNA) clearance
Measured over: 3 months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07823322 · record last updated 2026-09-22 · checked 2026-11-09 15:47 UTC